This is in line with our findings as we observed elevated expression of the results from the integrated analysis illustrating the elevated expression of receptor-modulating ligands FGF1, FGF3 and FGF20 (Figure 1E–G) in CCA. The gene discussed is FGF20; the disease is cholangiocarcinoma.